Joshua Reed
Director of Finance/CFO at OMEGA THERAPEUTICS, INC.
Net worth: - $ as of 2024-03-30
Profile
Joshua Reed is an Independent Director at Scholar Rock Holding Corp.
and the Chief Financial & Accounting Officer at Omega Therapeutics, Inc. He was previously the Vice President & Head-Finance Operations at Bristol Myers Squibb Co. from 2016 to 2018, Vice President-Strategic Business Development at JPMorgan Chase & Co. from 2002 to 2005, and the Chief Financial Officer & Treasurer at Aldeyra Therapeutics, Inc. from 2018 to 2022.
Reed received his undergraduate degree from Rutgers State University of New Jersey and his MBA from Stephen M.
Ross School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-06-20 | 0 ( -.--% ) | - $ | 2024-03-30 |
Joshua Reed active positions
| Companies | Position | Start |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Director/Board Member | 2021-03-17 |
| OMEGA THERAPEUTICS, INC. | Director of Finance/CFO | 2022-05-22 |
Former positions of Joshua Reed
| Companies | Position | End |
|---|---|---|
| ALDEYRA THERAPEUTICS, INC. | Director of Finance/CFO | 2022-05-09 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2018-06-30 |
| JPMORGAN CHASE & CO. | Corporate Officer/Principal | 2004-12-31 |
Training of Joshua Reed
| Rutgers State University of New Jersey | Undergraduate Degree |
| Stephen M. Ross School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| JPMORGAN CHASE & CO. | Finance |
| ALDEYRA THERAPEUTICS, INC. | Health Technology |
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| OMEGA THERAPEUTICS, INC. | Health Technology |
- Stock Market
- Insiders
- Joshua Reed
